GoodRx HoldingsGDRX +3.70%61 EV-to-FCF is 12.99 as of Jun. 27, 2026, which is 51% below its 10-year median of 26.53. GuruFocus rates GDRX with a GF Score™ of 61/100 and a GF Value™ of $5.66 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 410 Healthcare Providers & Services companies, GoodRx Holdings ranks better than 61.95% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, GoodRx Holdings's Enterprise Value is $1,253.9 Mil.
GoodRx Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $96.5 Mil. Therefore, GoodRx Holdings's EV-to-FCF for today is 12.99.
The historical rank and industry rank for GoodRx Holdings's EV-to-FCF or its related term are showing as below:
GDRX'
s EV-to-FCF Range Over the Past 10 Years
Min: 9.84 Med: 26.53 Max: 238.34
Current: 12.99
During the past 8 years, the highest EV-to-FCF of GoodRx Holdings was 238.34. The lowest was 9.84. And the median was 26.53.
GDRX's EV-to-FCF is ranked better than 61.95% of 410
companies
in the Healthcare Providers & Services industry
Industry Median: 17.435
vs GDRX: 12.99
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
GoodRx Holdings's PE Ratio (TTM) for today is calculated as:
GoodRx Holdings's share price for today is $2.80.
GoodRx Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.060.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
GoodRx Holdings EV-to-FCF Related Terms
GoodRx Holdings EV-to-FCF Historical Data
* Premium members only.
The historical data trend for GoodRx Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, GoodRx Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GoodRx Holdings EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GoodRx Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where GoodRx Holdings's EV-to-FCF falls into.
GoodRx Holdings's current Enterprise Value is $1,253.9 Mil.
GoodRx Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $96.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GoodRx Holdings (GDRX) has a EV-to-FCF of 12.99 as of Jun. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on GoodRx Holdings and its competitors. This is 51% below median its historical median of 26.53. Over the past decade, GoodRx Holdings' EV-to-FCF has ranged from 9.84 to 238.34. According to the industry distribution chart, GoodRx Holdings ranks #156 out of 410 companies in the Healthcare Providers & Services industry, placing it in the top 38%.
Is GoodRx Holdings' EV-to-FCF too high?
GoodRx Holdings' current EV-to-FCF of 12.99 is 51% below median its 10-year median of 26.53. Over the past 10 years, this metric has ranged from a low of 9.84 to a high of 238.34. The Healthcare Providers & Services industry median EV-to-FCF is 17.44. GoodRx Holdings' value of 12.99 is 25.5% below this industry median. Based on the distribution chart, GoodRx Holdings ranks #156 out of 410 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, GoodRx Holdings has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GoodRx Holdings' EV-to-FCF compare to OMDA and CERT?
According to the Healthcare Providers & Services industry distribution chart, GoodRx Holdings ranks #156 out of 410 companies for EV-to-FCF. This puts GoodRx Holdings in the upper half of its industry. The industry median EV-to-FCF is 17.44. GoodRx Holdings' value of 12.99 is 25.5% below this benchmark. Historically, GoodRx Holdings' own EV-to-FCF has ranged from 9.84 to 238.34 over the past decade. While the company's 10-year median is 26.53 vs. the industry median of 17.44, GoodRx Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.44, based on 410 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GoodRx Holdings's current EV-to-FCF of 12.99 is 25.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on GoodRx Holdings and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GoodRx Holdings's current EV-to-FCF is 12.99, which is 51% below median its own 10-year median of 26.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GoodRx Holdings stock overvalued right now?
Based on GuruFocus' analysis, GoodRx Holdings (GDRX) is currently considered Possible Value Trap. The stock's GF Value™ is $5.66, compared to a current price of $2.80 — trading 50.5% below its estimated fair value. The current EV-to-FCF is 12.99, which is 51% below median its 10-year median of 26.53 and 25.5% below the Healthcare Providers & Services industry median of 17.44. GoodRx Holdings' overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For GoodRx Holdings (GDRX), the current EV-to-FCF is 12.99 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GoodRx Holdings (GDRX) Overvalued in 2026?
Based on GuruFocus' analysis, GoodRx Holdings stock appears to be undervalued.
The current stock price of $2.80 is trading 50.5% below its estimated GF Value™ of $5.66.
GuruFocus considers GoodRx Holdings to be Possible Value Trap.
Key valuation signals for GDRX:
EV-to-FCF: 12.99 (51% below median its 10-year median of 26.53)
GF Value™: $5.66 vs. price of $2.80 (50.5% below fair value)
Industry Position: 25.5% below the Healthcare Providers & Services median (#156 of 410)
No single metric tells the full story. See the GDRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
61GF Score
Get the complete analysis for GDRX
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GDRX has been successfully added to your 
